Ramy Farid - 07 Feb 2023 Form 4 Insider Report for Structure Therapeutics Inc. (GPCR)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
09 Feb 2023, 18:09:23 UTC
Prior SEC filing
02 Feb 2023
Next SEC filing
10 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jun Yoon, Attorney-in-Fact

Key filing fact

Ramy Farid filed Form 4 for Structure Therapeutics Inc. (GPCR) on 09 Feb 2023.

Key facts

  • This page summarizes Ramy Farid's Form 4 filing for Structure Therapeutics Inc. (GPCR).
  • 3 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 09 Feb 2023, 18:09.

Change

  • Previous filing in this sequence was filed on 02 Feb 2023.
  • Current net transaction value: +$4,125,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GPCR transaction

Ordinary Shares

Conversion of derivative security

Transaction value
Shares
+642,245
Change %
+25%
Price
Shares after
3,260,495
Date
07 Feb 2023
Ownership
By Schrodinger, Inc.
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GPCR transaction Derivative

Series B Preferred Shares

Conversion of derivative security

Transaction value
Shares
-642,245
Change %
-100%
Price
Shares after
0
Date
07 Feb 2023
Ownership
By Schrodinger, Inc.
Underlying class
Ordinary Shares
Underlying amount
642,245
Exercise price
Footnotes
F1, F2
GPCR transaction Derivative

American Depositary Shares

Purchase

Transaction value
$4,125,000
Shares
+275,000
Change %
Price
$15.00
Shares after
275,000
Date
07 Feb 2023
Ownership
By Schrodinger, Inc.
Underlying class
Ordinary Shares
Underlying amount
825,000
Exercise price
Footnotes
F2, F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

All outstanding Preferred Shares automatically converted into Ordinary Shares immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one Ordinary Share for each one Preferred Share, based on the conversion price currently in effect. The Preferred Shares have no expiration date.

Footnote F2

The Reporting Person is President, Chief Executive Officer and a member of the board of directors of Schrodinger, Inc. ("Schrodinger") and may be deemed to share voting and dispositive power over the shares held by Schrodinger. The Reporting Person disclaims beneficial ownership of the shares held by Schrodinger.

Footnote F3

Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

Footnote F4

The American Depositary Shares were purchased in the Issuer's initial public offering.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .